LFM-A12

N/A

Report date: 2026/05/13 20:02:10

NME

Base Information

Drug NameLFM-A12

Drug Alias NameLFM-A12

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCaspase inhibitorsEpidermal growth factor receptor erbB1 inhibitors

TargetsEpidermal growth factor receptor erbB1Caspase

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHughes Institute

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesHughes Institute

Active IndicationsN/A

Inactive IndicationsBreast Neoplasms

ATC CodeN/A